Yiheng Capital Management as of Sept. 30, 2025
Portfolio Holdings for Yiheng Capital Management
Yiheng Capital Management holds 25 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Astera Labs Put Option (ALAB) | 41.2 | $280M | 1.4M | 195.80 | |
| Jd.com Spon Ads Cl A (JD) | 13.4 | $91M | 2.6M | 34.98 | |
| Noah Hldgs Spon Ads (NOAH) | 11.5 | $78M | 6.7M | 11.59 | |
| Bilibili Spons Ads Rep Z (BILI) | 7.5 | $51M | 1.8M | 28.09 | |
| New Oriental Ed & Technology Spon Adr (EDU) | 4.1 | $28M | 522k | 53.07 | |
| ViaSat Put Option (VSAT) | 3.2 | $22M | 736k | 29.30 | |
| H World Group Sponsored Ads (HTHT) | 2.6 | $18M | 457k | 39.11 | |
| Inventiva Sa Ads (IVA) | 2.3 | $15M | 2.6M | 5.79 | |
| Atre Sponsored Ads (RERE) | 2.1 | $15M | 3.2M | 4.60 | |
| Acm Resh Com Cl A (ACMR) | 1.6 | $11M | 280k | 39.13 | |
| Miragen Therapeutics (VRDN) | 1.6 | $11M | 500k | 21.58 | |
| Akero Therapeutics (AKRO) | 1.3 | $9.1M | 191k | 47.48 | |
| Kymera Therapeutics (KYMR) | 1.0 | $6.9M | 123k | 56.60 | |
| Denali Therapeutics (DNLI) | 1.0 | $6.8M | 470k | 14.52 | |
| Ultragenyx Pharmaceutical (RARE) | 1.0 | $6.8M | 226k | 30.08 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 1.0 | $6.6M | 656k | 10.00 | |
| Silvaco Group (SVCO) | 0.9 | $5.9M | 1.1M | 5.41 | |
| Pony Ai Sponsored Ads (PONY) | 0.7 | $4.5M | 200k | 22.49 | |
| Cellebrite Di Ordinary Shares (CLBT) | 0.6 | $4.3M | 231k | 18.53 | |
| Tal Education Group Sponsored Ads (TAL) | 0.5 | $3.5M | 309k | 11.20 | |
| Agora Ads (API) | 0.3 | $2.0M | 534k | 3.82 | |
| Beam Therapeutics (BEAM) | 0.2 | $1.7M | 69k | 24.27 | |
| Yatsen Hldg Sponsored Ads (YSG) | 0.1 | $873k | 96k | 9.06 | |
| Generation Bio Com New (GBIO) | 0.1 | $646k | 106k | 6.12 | |
| Tuniu Corp Sponsored Ads (TOUR) | 0.0 | $299k | 314k | 0.95 |
